Chromatin breakdown during necrosis by serum Dnase1 and the plasminogen system

Arthritis and Rheumatism

Volumn 50, Issue 6, 2004, Pages 1873-1883

  Napirei, Markus ^a,b   Wulf, Swantje ^a   Mannherz, Hans Georg ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; DEOXYRIBONUCLEASE I; DNA; DNA BINDING PROTEIN; ENZYME; HISTONE H1; HYDROGEN PEROXIDE; PLASMIN; PLASMINOGEN; STREPTOLYSIN O;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY TITER; ARTICLE; AUTOIMMUNITY; CATALYSIS; CELL DEATH; CELL LINE; CELL NUCLEUS; CELL STRAIN MCF 7; CHROMATIN; CONTROLLED STUDY; CULTURE MEDIUM; CYTOPLASM; CYTOSKELETON; DNA CLEAVAGE; DNA STRAND BREAKAGE; FREEZING; HUMAN; HUMAN CELL; IN VITRO STUDY; KNOCKOUT MOUSE; MOUSE; NONHUMAN; NUCLEOSOME; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN LOCALIZATION; SYSTEMIC LUPUS ERYTHEMATOSUS; THAWING;

ADENOCARCINOMA; ANIMALS; ANTIBODIES, ANTINUCLEAR; AUTOIMMUNITY; BREAST NEOPLASMS; CHROMATIN; DEOXYRIBONUCLEASE I; DNA; EXTRACELLULAR SPACE; HISTONES; HL-60 CELLS; HUMANS; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; NECROSIS; NIH 3T3 CELLS; PLASMINOGEN;

EID: 2642568607     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.20267     Document Type: Article

References (45)

1. Wallace DJ, Hahn BH, Quismorio FP Jr, Klinenberg JR, editors. Dubois' lupus erythematosus. 5th ed. Baltimore: Williams & Wilkins; 1997.
2. Cohen PL, Caricchio R, Abraham V, Camenisch TD, Jennette JC, Roubey RA, et al. Delayed apoptotic cell clearance and lupus-like autoimmunity in mice lacking the c-mer membrane tyrosine kinase. J Exp Med 2002;196:135-40.
3. Balomenos D, Martin-Caballero J, Garcia MI, Prieto I, Flores JM, Serrano M, et al. The cell cycle inhibitor p21 controls T-cell proliferation and sex-linked lupus development. Nat Med 2000;6: 171-6.
4. Napirei M, Karsunky H, Zevnik B, Stephan H, Mannherz HG, Moroy T. Features of systemic lupus erythematosus in Dnase1-deficient mice. Nat Genet 2000;25:177-81.
5. Bickerstaff MC, Botto M, Hutchinson WL, Herbert J, Tennent GA, Bybee A, et al. Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity. Nat Med 1999;5:694-7.
6. Nishimura H, Nose M, Hiai H, Minato N, Honjo T. Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity 1999;11:141-51.
7. O'Keefe TL, Williams GT, Batista FD, Neuberger MS. Deficiency in CD22, a B cell-specific inhibitory receptor, is sufficient to predispose to development of high affinity autoantibodies. J Exp Med 1999;189:1307-13.
8. Botto M, Dell'Agnola C, Bygrave AE, Thompson EM, Cook HT, Petry F, et al. Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat Genet 1998;19:56-9.
9. Cohen PL, Eisenberg RA. Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. Annu Rev Immunol 1991;9:243-69.
10. Walport MJ. Lupus, DNase and defective disposal of cellular debris. Nat Genet 2000;25:135-6.
11. Laskowski M. Deoxyribonuclease I. In: Boyer PD, Landy H, Myrback K, editors. The enzymes. 3rd ed. Vol. 4. New York: Academic Press; 1971. p. 289-311.
12. Lacks SA. Deoxyribonuclease I in mammalian tissues: specificity of inhibition by actin. J Biol Chem 1981;256:2644-8.
13. Mannherz HG, Peitsch MC, Zanotti S, Paddenberg R, Polzar B. A new function for an old enzyme: the role of DNase I in apoptosis. Curr Top Microbiol Immunol 1995;198:161-74.
14. Van Cruchten S, van den Broeck W. Morphological and biochemical aspects of apoptosis, oncosis and necrosis. Anat Histol Embryol 2002;31:214-23.
15. Duvall E, Wyllie AH. Death and the cell. Immunol Today 1986;7:115-9.
16. Wyllie AH, Kerr JF, Currie AR. Cell death: the significance of apoptosis. Int Rev Cytol 1980;68:251-306.
17. Nagata S. Apoptotic DNA fragmentation. Exp Cell Res 2000;256: 12-8.
18. Counis MF, Torriglia A. DNases and apoptosis. Biochem Cell Biol 2000;78:405-14.
19. Nicotera P, Leist M, Ferrando-May E. Intracellular ATP, a switch in the decision between apoptosis and necrosis. Toxicol Lett 1998;102-3:139-42.
20. Kok YJ, Swe M, Sit KH. Necrosis has orderly DNA fragmentations. Biochem Biophys Res Commun 2002;294:934-9.
21. Dong Z, Saikumar P, Weinberg JM, Venkatachalam MA. Internucleosomal DNA cleavage triggered by plasma membrane damage during necrotic cell death: involvement of serine but not cysteine proteases. Am J Pathol 1997;151:1205-13.
22. Fairbairn DW, O'Neill KL. Necrotic DNA degradation mimics apoptotic nucleosomal fragmentation comet tail length. In Vitro Cell Dev Biol Anim 1995;31:171-3.
23. Li LY, Luo X, Wang X. Endonuclease G is an apoptotic DNase when released from mitochondria. Nature 2001;412:95-9.
24. Rose GG. The circumfusion system for multipurpose culture chambers. I. Introduction to the mechanics, techniques, and basic results of a 12-chamber (in vitro) closed circulatory system. J Cell Biol 1967;32:89-112.
25. Bhakdi S, Weller U, Walev I, Martin E, Jonas D, Palmer M. A guide to the use of pore-forming toxins for controlled permeabilization of cell membranes. Med Microbiol Immunol (Berl) 1993; 182:167-75.
26. Stolzenberg I, Wulf S, Mannherz HG, Paddenberg R. Different sublines of Jurkat cells respond with varying susceptibility of internucleosomal DNA degradation to different mediators of apoptosis. Cell Tissue Res 2000;301:273-82.
27. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-5.
28. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual. 2nd ed. New York: Cold Spring Harbor Laboratory Press; 1989.
29. Peitsch MC, Hesterkamp T, Polzar B, Mannherz HG, Tschopp J. Functional characterisation of serum DNase I in MRL-lpr/lpr mice. Biochem Biophys Res Commun 1992;186:739-45.
30. Fritz H, Wunderer G. Biochemistry and applications of aprotinin, the kallikrein inhibitor from bovine organs. Arzneimittelforschung 1983;33:479-94.
31. Griffin JD, Ellman L. Epsilon-aminocaproic acid (EACA). Semin Thromb Hemost 1978;5:27-40.
32. Dobrovolsky AB, Titaeva EV. The fibrinolysis system: regulation of activity and physiologic functions of its main components. Biochemistry (Mosc) 2002;67:99-108.
33. Edelberg JM, Conrad HE, Pizzo SV. Heparin oligosaccharides enhance tissue-type plasminogen activator: a correlation between oligosaccharide length and stimulation of plasminogen activation. Biochemistry 1991;30:10999-1003.
34. Gaipl US, Kuenkele S, Voll RE, Beyer TD, Kolowos W, Heyder P, et al. Complement binding is an early feature of necrotic and a rather late event during apoptotic cell death. Cell Death Differ 2001;8:327-34.
35. Jiang H, Cooper B, Robey FA, Gewurz H. DNA binds and activates complement via residues 14-26 of the human C1q A chain. J Biol Chem 1992;267:25597-601.
36. Plow EF, Herren T, Redlitz A, Miles LA, Hoover-Plow JL. The cell biology of the plasminogen system. FASEB J 1995;9:939-45.
37. Carmeliet P, Collen D. Development and disease in proteinase-deficient mice: role of the plasminogen, matrix metalloproteinase and coagulation system. Thromb Res 1998;91:255-85.
38. Romer J, Bugge TH, Pyke C, Lund LR, Flick MJ, Degen JL, et al. Impaired wound healing in mice with a disrupted plasminogen gene. Nat Med 1996;2:287-92.
39. Dudani AK, Ganz PR. Endothelial cell surface actin serves as a binding site for plasminogen, tissue plasminogen activator and lipoprotein(a). Br J Haematol 1996;95:168-78.
40. Hembrough TA, Kralovich KR, Li L, Gonias SL. Cytokeratin 8 released by breast carcinoma cells in vitro binds plasminogen and tissue-type plasminogen activator and promotes plasminogen activation. Biochem J 1996;317:763-9.
41. Ranson M, Andronicos NM, O'Mullane MJ, Baker MS. Increased plasminogen binding is associated with metastatic breast cancer cells: differential expression of plasminogen binding proteins. Br J Cancer 1998;77:1586-97.
42. O'Mullane MJ, Baker MS. Elevated plasminogen receptor expression occurs as a degradative phase event in cellular apoptosis. Immunol Cell Biol 1999;77:249-55.
43. Staynov DZ. DNase I digestion reveals alternating asymmetrical protection of the nucleosome by the higher order chromatin structure. Nucleic Acids Res 2000;28:3092-9.
44. Iovcheva C, Mladenova I, Dessev G. Removal of histone H1 exposes linker DNA in chromatin to DNAse I. Mol Biol Rep 1984;10:9-12.
45. Szabo G Jr. 50-kb chromatin fragmentation in the absence of apoptosis. Exp Cell Res 1995;221:320-5.